Marinobufagenin, Left Ventricular Hypertrophy and Residual Renal Function in Kidney Transplant Recipients

Background: Left ventricular hypertrophy (LVH), which is a pervasive complication of end-stage kidney disease (ESKD), persists in some uremic individuals even after kidney transplantation (Ktx), contributing to worsening CV outcomes. Marinobufagenin (MBG), an endogenous steroid cardiotonic hormone e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolignano, Davide, Greco, Marta, Presta, Pierangela, Caglioti, Alfredo, Carullo, Nazareno, Zicarelli, Mariateresa, Foti, Daniela Patrizia, Dragone, Francesco, Andreucci, Michele, Coppolino, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179363/
https://www.ncbi.nlm.nih.gov/pubmed/37176512
http://dx.doi.org/10.3390/jcm12093072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179363/
https://www.ncbi.nlm.nih.gov/pubmed/37176512
http://dx.doi.org/10.3390/jcm12093072

Ejemplares similares